New strategy for the extension of the serum half-life of antibody fragments
S Trussel, C Dumelin, K Frey, A Villa… - Bioconjugate …, 2009 - ACS Publications
Antibody fragments can recognize their cognate antigen with high affinity and can be produced
at high yields, but generally display rapid blood clearance profiles. For pharmaceutical …
at high yields, but generally display rapid blood clearance profiles. For pharmaceutical …
Selection of carbonic anhydrase IX inhibitors from one million DNA-encoded compounds
F Buller, M Steiner, K Frey, D Mircsof… - ACS chemical …, 2011 - ACS Publications
DNA-encoded chemical libraries, ie, collections of compounds individually coupled to distinctive
DNA fragments serving as amplifiable identification barcodes, represent a new tool for …
DNA fragments serving as amplifiable identification barcodes, represent a new tool for …
Antibody-based delivery of interleukin-2 to neovasculature has potent activity against acute myeloid leukemia
…, C Schliemann, L Giovannoni, K Frey… - Science translational …, 2013 - science.org
Acute myeloid leukemia (AML) is a rapidly progressing disease that is accompanied by a
strong increase in microvessel density in the bone marrow. This observation prompted us to …
strong increase in microvessel density in the bone marrow. This observation prompted us to …
The PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasis
…, PS Zeiner, JM Messmer, DC Hoffmann, K Frey… - Neuro …, 2022 - academic.oup.com
Background Brain metastases (BM) are a frequent complication of malignant melanoma (MM),
with limited treatment options and poor survival. Prevention of BM could be more effective …
with limited treatment options and poor survival. Prevention of BM could be more effective …
Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation
K Frey, A Zivanovic, K Schwager, D Neri - Integrative Biology, 2011 - academic.oup.com
The antibody-mediated targeted delivery of cytokines, growth factors and immunomodulators
offers great potential for the therapy of cancer and other serious conditions. Interferon-…
offers great potential for the therapy of cancer and other serious conditions. Interferon-…
Combination of a bispecific antibody and costimulatory antibody-ligand fusion proteins for targeted cancer immunotherapy
N Hornig, V Kermer, K Frey, P Diebolder… - Journal of …, 2012 - journals.lww.com
Initiation of a tumor-directed immune response and appropriate modulation of its progress
are key issues in cancer immunotherapy. Combinatorial strategies addressing both aspects …
are key issues in cancer immunotherapy. Combinatorial strategies addressing both aspects …
The immunocytokine F8-IL2 improves the therapeutic performance of sunitinib in a mouse model of renal cell carcinoma
K Frey, C Schliemann, K Schwager… - The Journal of …, 2010 - auajournals.org
Purpose : We investigated the therapeutic action of F8-IL2, a fusion protein consisting of the
F8 antibody specific to the alternatively spliced extradomain-A of fibronectin, in diabody …
F8 antibody specific to the alternatively spliced extradomain-A of fibronectin, in diabody …
Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
…, AT Bauer, G Solecki, AS Berghoff, CD Mayer, K Frey… - Cancer research, 2023 - AACR
Tracking single extravasating cancer cells using multimodal correlative microscopy
uncovers a brain seeding mechanism involving endothelial remodeling driven by cancer cell–…
uncovers a brain seeding mechanism involving endothelial remodeling driven by cancer cell–…
Multicenter, cross‐sectional study of the costs of illness and cost‐driving factors in adult patients with epilepsy
LM Willems, M Hochbaum, K Frey, J Schulz… - …, 2022 - Wiley Online Library
Objective This study was undertaken to quantify epilepsy‐related costs of illness (COI) in
Germany and identify cost‐driving factors. Methods COI were calculated among adults with …
Germany and identify cost‐driving factors. Methods COI were calculated among adults with …
A novel antibody–4-1BBL fusion protein for targeted costimulation in cancer immunotherapy
D Müller, K Frey, RE Kontermann - Journal of Immunotherapy, 2008 - journals.lww.com
Costimulation is an essential step in T-cell activation and hence, represents an important
aspect in cancer immunotherapy. 4-1BB, a member of the tumor necrosis factor receptor family, …
aspect in cancer immunotherapy. 4-1BB, a member of the tumor necrosis factor receptor family, …